Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

siRNA and shRNA-mediated knock down (KD) methods of regulating gene expression are invaluable tools for understanding gene and protein function. However, in the case that the KD of the protein of interest has a lethal effect on cells or the anticipated effect of the KD is time-dependent, uncondition...

Full description

Saved in:
Bibliographic Details
Published inJournal of visualized experiments no. 129
Main Authors Kubala, Marta H., DeClerck, Yves A.
Format Journal Article
LanguageEnglish
Published United States MyJove Corporation 23.11.2017
Subjects
Online AccessGet full text
ISSN1940-087X
1940-087X
DOI10.3791/56333

Cover

Abstract siRNA and shRNA-mediated knock down (KD) methods of regulating gene expression are invaluable tools for understanding gene and protein function. However, in the case that the KD of the protein of interest has a lethal effect on cells or the anticipated effect of the KD is time-dependent, unconditional KD methods are not appropriate. Conditional systems are more suitable in these cases and have been the subject of much interest. These include Ecdysone-inducible overexpression systems, Cytochrome P-450 induction system , and the tetracycline regulated gene expression systems. The tetracycline regulated gene expression system enables reversible control over protein expression by induction of shRNA expression in the presence of tetracycline. In this protocol, we present an experimental design using functional Tet-ON system in human cancer cell lines for conditional regulation of gene expression. We then demonstrate the use of this system in the study of tumor cell-monocyte interaction.
AbstractList siRNA and shRNA-mediated knock down (KD) methods of regulating gene expression are invaluable tools for understanding gene and protein function. However, in the case that the KD of the protein of interest has a lethal effect on cells or the anticipated effect of the KD is time-dependent, unconditional KD methods are not appropriate. Conditional systems are more suitable in these cases and have been the subject of much interest. These include Ecdysone-inducible overexpression systems, Cytochrome P-450 induction system1, and the tetracycline regulated gene expression systems. The tetracycline regulated gene expression system enables reversible control over protein expression by induction of shRNA expression in the presence of tetracycline. In this protocol, we present an experimental design using functional Tet-ON system in human cancer cell lines for conditional regulation of gene expression. We then demonstrate the use of this system in the study of tumor cell-monocyte interaction.
siRNA and shRNA-mediated knock down (KD) methods of regulating gene expression are invaluable tools for understanding gene and protein function. However, in the case that the KD of the protein of interest has a lethal effect on cells or the anticipated effect of the KD is time-dependent, unconditional KD methods are not appropriate. Conditional systems are more suitable in these cases and have been the subject of much interest. These include Ecdysone-inducible overexpression systems, Cytochrome P-450 induction system1, and the tetracycline regulated gene expression systems. The tetracycline regulated gene expression system enables reversible control over protein expression by induction of shRNA expression in the presence of tetracycline. In this protocol, we present an experimental design using functional Tet-ON system in human cancer cell lines for conditional regulation of gene expression. We then demonstrate the use of this system in the study of tumor cell-monocyte interaction.siRNA and shRNA-mediated knock down (KD) methods of regulating gene expression are invaluable tools for understanding gene and protein function. However, in the case that the KD of the protein of interest has a lethal effect on cells or the anticipated effect of the KD is time-dependent, unconditional KD methods are not appropriate. Conditional systems are more suitable in these cases and have been the subject of much interest. These include Ecdysone-inducible overexpression systems, Cytochrome P-450 induction system1, and the tetracycline regulated gene expression systems. The tetracycline regulated gene expression system enables reversible control over protein expression by induction of shRNA expression in the presence of tetracycline. In this protocol, we present an experimental design using functional Tet-ON system in human cancer cell lines for conditional regulation of gene expression. We then demonstrate the use of this system in the study of tumor cell-monocyte interaction.
siRNA and shRNA-mediated knock down (KD) methods of regulating gene expression are invaluable tools for understanding gene and protein function. However, in the case that the KD of the protein of interest has a lethal effect on cells or the anticipated effect of the KD is time-dependent, unconditional KD methods are not appropriate. Conditional systems are more suitable in these cases and have been the subject of much interest. These include Ecdysone-inducible overexpression systems, Cytochrome P-450 induction system , and the tetracycline regulated gene expression systems. The tetracycline regulated gene expression system enables reversible control over protein expression by induction of shRNA expression in the presence of tetracycline. In this protocol, we present an experimental design using functional Tet-ON system in human cancer cell lines for conditional regulation of gene expression. We then demonstrate the use of this system in the study of tumor cell-monocyte interaction.
Author Kubala, Marta H.
DeClerck, Yves A.
AuthorAffiliation 3 Department of Biochemistry and Molecular Medicine, University of Southern California
1 Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Pediatrics, University of Southern California
2 The Saban Research Institute of Children's Hospital Los Angeles
AuthorAffiliation_xml – name: 2 The Saban Research Institute of Children's Hospital Los Angeles
– name: 1 Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Pediatrics, University of Southern California
– name: 3 Department of Biochemistry and Molecular Medicine, University of Southern California
Author_xml – sequence: 1
  givenname: Marta H.
  surname: Kubala
  fullname: Kubala, Marta H.
– sequence: 2
  givenname: Yves A.
  surname: DeClerck
  fullname: DeClerck, Yves A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29286360$$D View this record in MEDLINE/PubMed
BookMark eNqFkstu1DAUhi1URC_0FZA3SEhoWtuxHWeDhKJSEDNCglbqLnKck44hsae2U5iH4J1xOqUq3bCy5f87v8_tEO057wChY0pOirKip0IWRfEMHdCKkwVR5dXeo_s-OozxOyGSEaFeoH1WMSULSQ7Q79q7zibrnR7wZ-fNj87_dNj3-Bwc4LNfmwAxZhlbh2vtDARcwzDgpXUQcfL4W5q6LU5rwF_BhMmmEVyaDVY-220TxNOVNsFv1vp6FzGzF9PoA17ZLIC7tcG7Oewlet7rIcLx_XmELj-cXdQfF8sv55_q98uF4VSkhWh7ACYlSAG5dsW04gXvJOm5bvvWGN3zlirSsl5T0B2wtpAcqMhPFExZHKF3O9_N1I7Qmfx10EOzCXbUYdt4bZt_FWfXzbW_bUQpBC9VNnhzbxD8zQQxNaONJvdFO_BTbBgTRW6xqOR_UVoppjjjkmX01eO0HvL5O64MvN4BuW0xBugfEEqaeQ2auzXI3NsnnLFJz1PO1djhCf0Hmtm19w
CitedBy_id crossref_primary_10_3389_fimmu_2023_1295684
crossref_primary_10_1080_2162402X_2022_2146860
ContentType Journal Article
Copyright Copyright © 2017, Journal of Visualized Experiments 2017
Copyright_xml – notice: Copyright © 2017, Journal of Visualized Experiments 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
DOI 10.3791/56333
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1940-087X
ExternalDocumentID PMC5755478
29286360
10_3791_56333
Genre Video-Audio Media
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GroupedDBID ---
223
29L
53G
5GY
AAHBH
AAHTB
AAYXX
ABPEJ
ACGFO
ADBBV
AKRSQ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
CS3
DIK
E3Z
GX1
HYE
OK1
RPM
SJN
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c415t-5bfee266e65e79182a8434d60f4abfbccaf4b180b2fa1eade2b364e1580b1ec73
ISSN 1940-087X
IngestDate Tue Sep 30 17:00:42 EDT 2025
Fri Jul 11 11:25:24 EDT 2025
Thu Jul 10 21:07:42 EDT 2025
Mon Jul 21 05:42:23 EDT 2025
Tue Jul 01 05:22:19 EDT 2025
Thu Apr 24 22:59:40 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 129
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c415t-5bfee266e65e79182a8434d60f4abfbccaf4b180b2fa1eade2b364e1580b1ec73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Correspondence to: Marta H. Kubala at mkubala@chla.usc.edu
OpenAccessLink https://www.jove.com/pdf/56333/conditional-knockdown-gene-expression-cancer-cell-lines-to-study
PMID 29286360
PQID 1982842462
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5755478
proquest_miscellaneous_2253286596
proquest_miscellaneous_1982842462
pubmed_primary_29286360
crossref_primary_10_3791_56333
crossref_citationtrail_10_3791_56333
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-11-23
PublicationDateYYYYMMDD 2017-11-23
PublicationDate_xml – month: 11
  year: 2017
  text: 2017-11-23
  day: 23
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of visualized experiments
PublicationTitleAlternate J Vis Exp
PublicationYear 2017
Publisher MyJove Corporation
Publisher_xml – name: MyJove Corporation
References 19916862 - Exp Lung Res. 2009 Nov;35(9):795-805
24812208 - Science. 2014 May 23;344(6186):921-5
28586002 - Int J Mol Med. 2017 Aug;40(2):483-490
11304683 - Int J Cancer. 2001 May 15;92(4):497-502
20133564 - Science. 2010 Feb 5;327(5966):656-61
15464949 - Anal Biochem. 2004 Nov 1;334(1):9-19
12028485 - J Oral Rehabil. 2002 May;29(5):401-7
28599497 - Oncol Lett. 2017 Jun;13(6):4925-4932
18835034 - Cancer Cell. 2008 Oct 7;14(4):324-34
25063025 - Biochem Biophys Res Commun. 2014 Aug 8;450(4):1696-701
9815678 - Clin Cancer Res. 1997 Feb;3(2):233-9
22984202 - J Natl Cancer Inst. 2012 Oct 3;104(19):1470-84
18755892 - Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13057-62
11731081 - Biochim Biophys Acta. 2001 Nov 7;1568(1):21-9
10733742 - Mem Inst Oswaldo Cruz. 2000 Mar-Apr;95(2):221-3
28117416 - Nat Rev Clin Oncol. 2017 Jul;14(7):399-416
27659097 - Arterioscler Thromb Vasc Biol. 2016 Nov;36(11):2167-2175
16601674 - EMBO J. 2006 May 3;25(9):1860-70
25697568 - Crit Rev Biotechnol. 2016 Aug;36(4):630-8
234920 - Int Arch Allergy Appl Immunol. 1975;48(3):341-52
11818362 - FASEB J. 2002 Feb;16(2):147-54
19177017 - Cell Cycle. 2009 Feb 1;8(3):498-504
6970727 - Int J Cancer. 1980 Aug;26(2):171-6
12885912 - J Virol. 2003 Aug;77(16):8957-61
23818743 - Mediators Inflamm. 2013;2013:697972
8083595 - J Leukoc Biol. 1994 Sep;56(3):236-40
9386191 - Circulation. 1997 Nov 4;96(9):3180-91
16862142 - Nat Cell Biol. 2006 Aug;8(8):877-84
25858805 - Cancer Cell. 2015 Apr 13;27(4):462-72
11572785 - J Endocrinol. 2001 Oct;171(1):1-14
15576901 - Methods Mol Biol. 2005;294:15-22
2010620 - J Immunol Methods. 1991 Mar 1;137(1):89-94
25838373 - Science. 2015 Apr 3;348(6230):56-61
25164011 - Cancer Res. 2014 Nov 1;74(21):5999-6009
12941798 - Cancer Res. 2003 Aug 15;63(16):4801-4
22768182 - PLoS One. 2012;7(6):e39956
References_xml – reference: 22768182 - PLoS One. 2012;7(6):e39956
– reference: 19916862 - Exp Lung Res. 2009 Nov;35(9):795-805
– reference: 11572785 - J Endocrinol. 2001 Oct;171(1):1-14
– reference: 2010620 - J Immunol Methods. 1991 Mar 1;137(1):89-94
– reference: 18755892 - Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13057-62
– reference: 12941798 - Cancer Res. 2003 Aug 15;63(16):4801-4
– reference: 9386191 - Circulation. 1997 Nov 4;96(9):3180-91
– reference: 25858805 - Cancer Cell. 2015 Apr 13;27(4):462-72
– reference: 10733742 - Mem Inst Oswaldo Cruz. 2000 Mar-Apr;95(2):221-3
– reference: 234920 - Int Arch Allergy Appl Immunol. 1975;48(3):341-52
– reference: 16862142 - Nat Cell Biol. 2006 Aug;8(8):877-84
– reference: 9815678 - Clin Cancer Res. 1997 Feb;3(2):233-9
– reference: 8083595 - J Leukoc Biol. 1994 Sep;56(3):236-40
– reference: 25063025 - Biochem Biophys Res Commun. 2014 Aug 8;450(4):1696-701
– reference: 25838373 - Science. 2015 Apr 3;348(6230):56-61
– reference: 15464949 - Anal Biochem. 2004 Nov 1;334(1):9-19
– reference: 6970727 - Int J Cancer. 1980 Aug;26(2):171-6
– reference: 24812208 - Science. 2014 May 23;344(6186):921-5
– reference: 27659097 - Arterioscler Thromb Vasc Biol. 2016 Nov;36(11):2167-2175
– reference: 25164011 - Cancer Res. 2014 Nov 1;74(21):5999-6009
– reference: 11818362 - FASEB J. 2002 Feb;16(2):147-54
– reference: 16601674 - EMBO J. 2006 May 3;25(9):1860-70
– reference: 28586002 - Int J Mol Med. 2017 Aug;40(2):483-490
– reference: 28117416 - Nat Rev Clin Oncol. 2017 Jul;14(7):399-416
– reference: 18835034 - Cancer Cell. 2008 Oct 7;14(4):324-34
– reference: 28599497 - Oncol Lett. 2017 Jun;13(6):4925-4932
– reference: 19177017 - Cell Cycle. 2009 Feb 1;8(3):498-504
– reference: 23818743 - Mediators Inflamm. 2013;2013:697972
– reference: 25697568 - Crit Rev Biotechnol. 2016 Aug;36(4):630-8
– reference: 11304683 - Int J Cancer. 2001 May 15;92(4):497-502
– reference: 12885912 - J Virol. 2003 Aug;77(16):8957-61
– reference: 11731081 - Biochim Biophys Acta. 2001 Nov 7;1568(1):21-9
– reference: 20133564 - Science. 2010 Feb 5;327(5966):656-61
– reference: 15576901 - Methods Mol Biol. 2005;294:15-22
– reference: 12028485 - J Oral Rehabil. 2002 May;29(5):401-7
– reference: 22984202 - J Natl Cancer Inst. 2012 Oct 3;104(19):1470-84
SSID ssj0062058
Score 2.1436043
Snippet siRNA and shRNA-mediated knock down (KD) methods of regulating gene expression are invaluable tools for understanding gene and protein function. However, in...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
SubjectTerms Animals
Breast Neoplasms - genetics
Breast Neoplasms - pathology
Cancer Research
Cell Line, Tumor
Cell Movement - physiology
Colonic Neoplasms - genetics
Colonic Neoplasms - pathology
cytochrome P-450
experimental design
Female
gene expression regulation
Gene Knockdown Techniques - methods
gene overexpression
genes
HCT116 Cells
human cell lines
Humans
macrophages
Macrophages - pathology
monocytes
Monocytes - pathology
neoplasm cells
neoplasms
protein synthesis
RNA, Small Interfering - genetics
small interfering RNA
tetracycline
Tumor Microenvironment
Title Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
URI https://www.ncbi.nlm.nih.gov/pubmed/29286360
https://www.proquest.com/docview/1982842462
https://www.proquest.com/docview/2253286596
https://pubmed.ncbi.nlm.nih.gov/PMC5755478
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1940-087X
  dateEnd: 20181231
  omitProxy: true
  ssIdentifier: ssj0062058
  issn: 1940-087X
  databaseCode: DIK
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1940-087X
  dateEnd: 20231001
  omitProxy: true
  ssIdentifier: ssj0062058
  issn: 1940-087X
  databaseCode: GX1
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1940-087X
  dateEnd: 20181231
  omitProxy: true
  ssIdentifier: ssj0062058
  issn: 1940-087X
  databaseCode: RPM
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb5wwELW2qVpVqqJ-d9s0cqXcIjZgwMAxQolWbdNLN9L2RG0wykpbqAhUSv5D_3NnbJYFkqgfF4SMDYh5jJ_tmWdCDsDjYwpJbqUumMHLMtsSbhRafoZaJMJzHIXJyWef-fzc-7D0l5PJt17UUlPLWXp9a17J_1gVysCumCX7D5btbgoFcA72hSNYGI5_ZeO4xAVnM5n3sQDPlsGYGukfikmjirEJctXBjDGatzqMca7uE8a6I-v8oiWlkXsifWxW9SY0AH71Mr2q0Yecngnc5utCtGoQWHvRfC8rDLmvyl6m3B1E9-fqEjM3r4HabvcT6K0hSbEWbdpQLQ7ns45bq3itKuOuv6I47vGsP0cB_Z7jWCaNuHWrEQaRhsHS9Dq3lLUoM7MfY7fuBhG6dZ-7RjRjKJs96s66IEMY3mDDRDe7R-6zgHO2mc8xfTVntt7BtXuXh-Rx-7wj3WzIVm4MQcaRtD1qsnhCdttPTY8NQJ6SiSqekQdml9Gr5-RXDya0gwktc4owoVuY0FVBDUwowoRqmNC6pBomFAxPezDBG3QwOeqBBFtgXQ0SOgbJC3J-erKI51a7C4eVArmrLV_mSgGNU9xX8F1CJkLP9TJu556QuQQPkHvSCW3JcuFg-D2TLveU40MR_OiB-5LsFGWhXhMaOanUOl-p1KpOQoZAGH3BZRRlQcam5GDztZO0lajHnVLWycCWU7LfVfthNFnGFd5vTJWAt8QlMFGosrlMnCgEPsY8zu6uAz2ci_naEZ-SV8a83WNYBFdcbk9JMDB8VwHV2odXitWFVm2HcRFq573508u_JY-2v9Ae2amrRr0D4lvLfY3d310UtqY
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Conditional+Knockdown+of+Gene+Expression+in+Cancer+Cell+Lines+to+Study+the+Recruitment+of+Monocytes%2FMacrophages+to+the+Tumor+Microenvironment&rft.jtitle=Journal+of+visualized+experiments&rft.au=Kubala%2C+Marta+H.&rft.au=DeClerck%2C+Yves+A.&rft.date=2017-11-23&rft.issn=1940-087X&rft.eissn=1940-087X&rft.issue=129&rft_id=info:doi/10.3791%2F56333&rft.externalDBID=n%2Fa&rft.externalDocID=10_3791_56333
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1940-087X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1940-087X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1940-087X&client=summon